The generality of inducing new antigens by targeting key mediators of antigen processing is suggested by the observation that downregulation of the ER aminopeptidase associated with antigen processing (ERAAP) also inhibits tumor growth and synergizes with PD-1 Ab treatment (Supplementary Fig. 3b). Here, ERAP1 is linked to neoplasm.